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Abstract: N-glycosylation of E-cadherin has been shown to inhibit cell–cell adhesion.
Specifically, our recent studies have provided evidence that the reduction of E-cadherin
N-glycosylation promoted the recruitment of stabilizing components, vinculin and serine/
threonine protein phosphatase 2A (PP2A), to adherens junctions (AJs) and enhanced the
association of AJs with the actin cytoskeleton. Here, we examined the details of how
N-glycosylation of E-cadherin affected the molecular organization of AJs and their cytoskeletal
interactions. Using the hypoglycosylated E-cadherin variant, V13, we show that V13/β-catenin
complexes preferentially interacted with PP2A and with the microtubule motor protein dynein.
This correlated with dephosphorylation of the microtubule-associated protein tau, suggesting that
increased association of PP2A with V13-containing AJs promoted their tethering to microtubules.
On the other hand, V13/γ-catenin complexes associated more with vinculin, suggesting that they
mediated the interaction of AJs with the actin cytoskeleton. N-glycosylation driven changes in the
molecular organization of AJs were physiologically significant because transfection of V13 into
A253 cancer cells, lacking both mature AJs and tight junctions (TJs), promoted the formation of
stable AJs and enhanced the function of TJs to a greater extent than wild-type E-cadherin. These
studies provide the first mechanistic insights into how N-glycosylation of E-cadherin drives
changes in AJ composition through the assembly of distinct β-catenin- and γ-catenin-containing
scaffolds that impact the interaction with different cytoskeletal components.
Keywords: E-cadherin, N-glycosylation, PP2A, microtubules, actin cytoskeleton
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Epithelial cell–cell adhesion is predominantly mediated by E-cadherin, a calciumdependent cell adhesion receptor.1–3 E-cadherin is a transmembrane protein containing
five extracellular domains or ectodomains (ECs) that dimerize to form homotypic
cell-cell contacts with E-cadherin on adjacent cells.4 The stability of these intercellular
contacts is regulated by the ability of E-cadherin’s cytoplasmic domain to organize
dynamic multiprotein complexes at the plasma membrane known as adherens junctions
(AJs).5 The cytosolic tail of E-cadherin binds catenins that mediate the interaction
with the actin cytoskeleton.6 The latter is mediated by α-, β-, γ-catenins, and vinculin,
with β-catenin and γ-catenin binding directly to the cytoplasmic tail in a mutually
exclusive manner. α-catenin then binds to either β- or γ-catenin where it plays a role
in the recruitment of the actin cytoskeleton and the organization of actin filaments at
the plasma membrane.6–9
In addition to its well acknowledged interaction with the actin cytoskeleton,
E-cadherin has been shown to interact with microtubules (MTs). These cytoskeletal
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interactions have been found to reinforce AJs and to
contribute to their stability and strength.8,10–12 While the
connection between E-cadherin and the actin cytoskeleton
has been studied extensively,13 less is known about the
relationships between E-cadherin and MTs. Nonetheless,
β-catenin has been reported to bind to the microtubulebased motor protein dynein, suggesting that E-cadherin
complexes and MTs connect physically.14 Moreover, AJs
and MTs may cooperate functionally since AJs can recruit
MTs and to support local accumulation of E-cadherin at
cell-cell contacts.10
E-cadherin can be post-translationally modified by
N-glycosylation of EC4 and EC5.15 N-Glycans modify
proteins at asparagine residues within the consensus sequence
NX(S/T), where X can be any amino acid with the exception
of proline.16,17 Not every potential N-glycan addition site on
a given N-glycoprotein is modified, and there are frequently
variations in the number of sites occupied by N-glycans, their
overall sizes and composition. We and others have shown that
the presence of complex N-glycans on EC4 interferes with
intercellular adhesion and actin cytoskeletal association.15,18
Accordingly, hypoglycosylated E-cadherin is a signature of
mature AJs. E-cadherin N-glycosylation is physiologically
significant because it is subject to changes with cellular
proliferation. Complex N-glycans preferentially modify
E-cadherin in proliferating and cancer cells while high mannose/hybrid structures are characteristic of growth-arrested
and differentiated cells. Indeed, our recent studies have shown
that modification of E-cadherin with complex N-glycans
leads to cellular discohesion and increased invasiveness of
oral cancer cells in vivo.19
One of the characteristic features of hypoglycosylated
E-cadherin is its increased recruitment of γ-catenin, vinculin,
and serine/threonine protein phosphatase 2A (PP2A) to
AJs.15,19 γ-catenin and vinculin have been shown to play
stabilizing roles in AJs.12,15,20–22 The function of PP2A in
AJs is unclear, although several observations indicate that
PP2A is critical for the maintenance of E-cadherin-mediated
cell–cell contacts.23 PP2A plays critical roles in cell growth,
signaling, and tumor suppression,24–26 and its dysregulation
has been linked to the destabilization of MT populations in
numerous cell types.27–29
We have been interested in deciphering how
N-glycosylation impacts cytoskeletal association and
adhesive function of E-cadherin scaffolds in normal
and cancer cells. In the present study, we examined the
relationship between the E-cadherin N-glycan-dependent
recruitment of PP2A to AJs and microtubule-stabilizing
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and motor proteins. We provide evidence that reduced
N-glycosylation of E-cadherin enhances its association
with the MT-associated protein (MAP), dynein, shown to
tether MTs to AJs. This interaction involves hypoglycosylated E-cadherin/β-catenin complexes that preferentially
associate with PP2A. The association of PP2A with AJs
correlates with a decreased phosphorylation of another
MAP, tau. On the other hand, hypoglycosylated E-cadherin/
γ-catenin complexes interact preferentially with vinculin,
suggesting that they mediate the association of mature
AJs with the actin cytoskeleton. Consistent with its role in
promoting cell-cell adhesion, transfection of hypoglycosylated E-cadherin into CHO cells and human epidermoid
carcinoma A253 cells enhances transepithelial resistance.
Collectively, our studies show for the first time that hypoglycosylated E-cadherin drives intercellular adhesion
through the formation of distinct protein complexes that
promote the interaction with the two major components of
the cytoskeleton, actin microfilaments and MTs.

Materials and methods
Reagents

Monoclonal antibodies to α-catenin, β-catenin, γ-catenin,
the cytoplasmic region of human E-cadherin, PP2A, and
IgG isotype controls were obtained from BD Biosciences
(Franklin Lakes, NJ, USA). Monoclonal antibody to
vinculin (clone V284) was from Upstate Biotechnology
(Charlottesville, VA, USA). Monoclonal antibody to
actin (pan Ab-5, clone ACTN05) was from NeoMarkers
(Fremont, CA, USA). Monoclonal antibody to α-tubulin
was from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Monoclonal antibodies to acetylated α-tubulin
and Flag were obtained from Sigma-Aldrich (St. Louis,
MO, USA). Monoclonal antibody to the GST tag was
purchased from Molecular Probes (Carlsbad, CA, USA)
and that to dynein from GeneTex Corporation (Zeeland,
MI, USA). Polycolonal antibodies to tau (Ab-231), tau
(Phosphor-Ser199) and tau (Phosphor-Thr231) were obtained
from GenScript Corporation (Piscataway, NJ, USA).
ProFound Co-Immunoprecipitation Kit was purchased from
Pierce Biotechnology (Rockford, IL, USA). Secondary
antibodies for immunostaining included fluorescein
isothiocyanate (FITC) and Texas red (Molecular Probes).
For Western blot analyses, horseradish peroxidase conjugated secondary antibodies were obtained from Amersham
Biosciences (Fairfield, CT, USA). Protein G Sepharose and
Glutathione Sepharose 4B beads were purchased from GE
Healthcare (Piscataway, NJ, USA).
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Vector construction and in vitro
mutagenesis
Human E-cadherin (GenBankTM accession no. Z13009)
was cloned into pCMV5Bmyc vector (Stratagene, La Jolla,
CA, USA) and tagged at the C-terminus with either a GST
tag or a Flag tag. The E-cadherin N-glycosylation variant
V13, lacking site 1 in EC4 and site 3 in EC5, was generated using a QuikChange XL site-directed mutagenesis kit
(Stratagene) as described by the manufacturer. The mutations
were verified by sequencing.

Cell culture, transfection, and preparation
of total cell lysates (TCLs)
CHO and human epidermoid carcinoma A253 cells were grown
in minimum essential alpha medium (Invitrogen, Carlsbad,
CA, USA) and McCoy’s medium (Invitrogen), respectively,
supplemented with 10% fetal calf serum, penicillin and
streptomycin in 5% CO2 at 37 °C. CHO and A253 cells
were transfected at 50% confluence with E-cadherin and
its N-glycosylation variant V13 using Lipofectamine 2000
(Invitrogen). Transfectants were cultured until full confluence
in the presence of 0.8 µg/ml G418 (Invitrogen). TCLs were
prepared using either Triton/Octylglucoside or RIPA buffers, as
described previously.15 Protein concentrations were determined
using the BCA protein assay (Pierce Biotechnology).

Western blot

TCLs (10 µg total protein) were fractionated on 7.5%
SDS-PAGE and transferred onto PVDF membranes. Nonspecific binding was reduced by blocking with 10% nonfat dry
milk in phosphate-buffered saline (PBS) at room temperature
(RT) for one hour. The membranes were incubated with
primary antibodies in PBS with 1% milk for one hour at
RT. Next, membranes were washed four times with 1X PBS
with 0.1% Tween 20, followed by incubation with horseradish peroxidase-linked secondary antibody (1:3000) in PBS
with 1% milk. Secondary antibodies were detected using
the ECL Plus Detection Reagents (Amersham Biosciences).
Immunoblots were scanned and densitometric analyses
were performed using Kodak 1D software (Eastman Kodak
Company, Rochester, NY, USA). Error bars represent standard deviation from three independent experiments; P values
were calculated by two-tailed t-test.

Surface biotinylation
CHO cells, transfected with either wild-type E-cadherin or
its hypoglycosylated variant V13, were surface biotinylated
using Sulfo-NHS-LC-Biotin according to manufacturer’s
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instructions (Pierce Biotechnology). Biotinylated transfectants were extracted with the lysis buffer, biotin-labeled
protein fractions were isolated with streptavidin agarose
beads, and surface labeled wild-type and V13 E-cadherins
were detected by Western blot using an antibody that recognizes E-cadherin’s cytoplasmic domain.

Immunoprecipitation and GST pulldown

TCLs (300 µg total protein) from CHO cells, transfected with
either E-cadherin or V13, were precleared with 100 µl of
Sepharose 4B beads and isotype control antibodies. For GST
pulldowns, the supernatants were incubated with Glutathione
Sepharose 4B beads. For immunoprecipitations of either β- or
γ-catenin protein complexes, supernatants were incubated with
antibodies to either β- or γ-catenin, followed by protein G beads.
The Glutathione Sepharose 4B beads and protein G beads
were washed three times with lysis buffer (10 mM Tris HCL
pH 7.5, 1 mM EDTA, 1 mM EGTA, and 0.5% Triton X-100).
Samples were resuspended in 100 µl LSB, boiled for 5 minutes
at 95 °C and analyzed by Western blot. For immunoprecipitations of E-cadherin and V13 from A253 cells transfected with
either E-cadherin or V13, a Flag antibody was used.

Double IP
Native, intact E-cadherin protein complexes were isolated from
CHO cells transfected with the hypoglycosylated E-cadherin
variant V13 using the ProFound Co-Immunoprecipitation Kit.
E-cadherin-specific antibody was immobilized by coupling
antibody to aldehyde activated gel beads (AminoLink Plus
Coupling Gel), as indicated by the manufacturer. TCLs
from V13 transfectants, grown in the presence of G418 to
confluence, were first precleared with nonactivated beads
and then incubated with immobilized antibody at 4 °C for
2 h. V13 complexes were eluted from the column using a
nonreducing elution buffer provided by the manufacturer
and diluted in Triton buffer. Next, intact V13 complexes
lacking the E-cadherin antibody were subjected to a second
immunoprecipitation using antibody to either β-catenin or
γ-catenin. The immunoprecipitates were then analyzed for
associated proteins by Western blot.

Microscopy and immunofluorescence
A253 cells were fixed in 3.7% paraformaldehyde and
permeabilized with 0.1% Triton X-100. The samples
were blocked with goat serum, rinsed with PBS, and
incubated with primary antibodies overnight at 4 °C. Cells
were then incubated with FITC- and Texas red-tagged
secondary antibodies and rhodamine-tagged phalloidin.
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Next, cells were rinsed four times with PBS and mounted
in Vectashield (Vector Laboratories, Inc., Burlingame, CA,
USA). The immunostained samples were analyzed with a
Zeiss confocal laser scanning microscope LSM510 META
(Fluar 5X/0.25, magnification Plan-Apochromat 40X/1.3
oil DIC). For visualization of individual optical sections and
for generation of Z-stacks with optical slices of 0.74 µm,
LSM 510-expert mode acquisition software was used. To
ensure valid comparison of fluorescence intensities between
samples, settings were fixed to the most highly stained sample
and all other images were acquired at those settings.

Transepithelial resistance
The effects of the hypoglycosylated V13 variant on
transepithelial resistance (TER) were measured in CHO and
A253 cells seeded onto Transwells (polycarbonate membrane, 12-mm diameter, 0.4 µm pore size; Corning Costar)
at 5 × 104 cells/cm2, grown to 50% confluence and transfected
with either wild-type E-cadherin or its hypoglycosylated
variant, V13. Transfectants were grown to high density
and TER was measured directly in culture media using
an epithelial voltohmmeter (World Precision Instruments,
Sarasota, FL, USA). Values were calculated after subtracting
background readings from blank Transwells with the media
that were cultured in parallel. Statistical analysis of the data
was by ANOVA.

Results
Hypoglycosylated E-cadherin is targeted
to the cell surface in CHO cells
Although CHO cells do not express endogenous E-cadherin,
they have been shown to organize E-cadherin-containing
AJs at the cell surface upon transfection with exogenous
E-cadherin.4,30 Previously, we reported that the hypoglycosylated E-cadherin variant V13 organized AJs with more
stabilizing proteins and in a greater association with the
actin cytoskeleton compared to wild-type E-cadherin.15
Since N-glycosylation has been shown to influence protein
folding and secretion, we examined whether the removal
of E-cadherin’s two N-glycans in variant V13 affected its
expression and targeting to the cell surface in CHO cells.
Total cell lysates (TCLs) from cells transfected with either
wild-type GST-E-cadherin or GST-V13 displayed similar
levels of E-cadherin expression after normalization to actin,
with the expected increased migration of V13 due to its hypoglycosylated status (Figure 1A). No GST-specific signal was
detected in untransfected CHO cells (Figure 1A). Comparison
of the abundance of E-cadherin’s immediate binding partners,
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GST

IP: Biotin
CHO E-cad V13

WB:
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V13

GST

β-catenin
γ-catenin
Actin
Figure 1 Hypoglycosylated E-cadherin V13 localizes to the cell surface. (A) Western
blot (WB) of wild-type E-cadherin (E-cad) and its hypoglycosylated variant V13 (V13),
and of associated catenins, expression levels. (B) E-cad- and V13-transfected cells
were biotinylated and equal amounts of biotin immunoprecipitates were analyzed
for E-cadherin expression by WB. Biotinylated V13 is expressed at levels similar
to E-cad.

β- and γ-catenins, did not reveal significant differences
among untransfected cells and either of the transfectants
(Figure 1A). To determine if the targeting of V13 to the cell
membrane was influenced by its reduced N-glycosylation
status, we labeled the surface pools of E-cadherin in
GST-E-cadherin- and GST-V13-transfected CHO cells with
biotin and analyzed them by Western blot. Figure 1B shows
that biotinylated pools of GST-E-cadherin and GST-V13
were comparable in abundance, with biotinylated GSTV13 displaying an expected mobility shift. Hence, reduced
N-glycosylation did not interfere with the targeting of V13
to the cell surface in CHO cells.

β-catenin complexes preferentially
associate with PP2A in V13-transfected
CHO cells
Association of AJs with PP2A has been shown to stabilize
intercellular adhesion.23,31,32 Our recent studies have provided
evidence that this is likely dependent on the N-glycosylation
status of E-cadherin, because excessive N-glycosylation
of E-cadherin in oral cancer cells and tissues is associated
with diminished recruitment of PP2A to AJs.19 To examine
whether E-cadherin N-glycosylation also impacted the
association of PP2A with AJs in CHO cells transfected
with either GST-E-cadherin or GST-V13, we assessed the
abundance of PP2A in GST pulldowns. Results showed
a four-fold increase in the amount of PP2A associated
with V13-protein complexes compared to E-cadherin
(Figure 2A, left panel). The specificity of the association
was confirmed in control experiments with Sepharose beads
alone (Figure 2A, right panel).
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One important function of PP2A resides in the stabilization
and growth of microtubules (MTs) through dephosphorylation of two microtubule associated proteins (MAPs), tau
and dynein.33–36 Tau regulates the growth and stabilization
of MTs while dynein is a motor protein that regulates MT
dynamics. Both MAPs are active in their dephosphorylated
state and both are substrates of PP2A.37–39 Importantly,
dynein has also been shown to tether MTs to AJs by binding β-catenin.14,40 Thus, it was possible that the increased
binding of β-catenin complexes to PP2A played a role
in the association with MTs. To test this hypothesis, we
examined the effects of E-cadherin N-glycosylation on
the phosphorylation state of tau and on the interaction of
dynein with β-catenin.
Cell lysates from E-cadherin- and V13-expressing cells
did not display significant changes in the levels of α-tubulin,
although the abundance of its acetylated form was increased
in V13 cells (Figure 3A). Acetylated tubulin has been shown
to contribute to the stability of MTs,41,42 although the relationship between the acetylation of tubulin and PP2A is unclear.
While total expression of tau was not markedly different in
TCLs from E-cadherin- and V13-transfected cells (Figure 3B),
its phosphorylation status was significantly diminished in
V13 cells (Figure 3C). This was the case for both serine and
threonine phosphorylation (Figure 3C). These data suggest
that increased recruitment of PP2A to β-catenin complexes
plays a role in the stabilization of MTs through the dephosphorylation of tau.

V13

E-cad

V13

GST

Fold change in
protein level

Although the recruitment of PP2A to AJs is known to
stabilize cell-cell adhesion, its biological significance has
not been determined. To gain insights into the function of
PP2A in AJs, we first asked whether the increased association of PP2A in V13-expressing cells was mediated by either
β-catenin or γ-catenin. Examination of the abundance of
PP2A in β-catenin immunoprecipitates from E-cadherin- and
V13-transfected CHO cells revealed an increased (2.8-fold)
association in V13-expressing cells (Figure 2B, left panel).
In contrast, no significant change was detected in the recruitment of PP2A to γ-catenin complexes from E-cadherin and
V13-transfected cells (Figure 2C, left panel). The specificity
of interactions of PP2A with β- and γ-catenins was confirmed
with isotype controls (Figures 2B and C, right panels). These
data indicate that PP2A is preferentially recruited to β-catenin
in V13 expressing cells.

N-glycosylation status of E-cadherin

Figure 2 PP2A preferentially associates with β-catenin in V13-transfected cells.
(A) The hypoglycosylated variant V13 (V13) recruits more PP2A than wild-type
E-cadherin (E-cad). Left panel, GST pulldown samples from CHO cells transfected
with either E-cad or V13 were assessed for association with PP2A by Western blot
(WB). Bargraph, Fold change of PP2A protein level from V13 cells was determined
in comparison with E-cad cells after normalization to GST (*P  0.05). Right
panel, Controls for specificity of GST pulldown. (B) PP2A preferentially binds to
β-catenin complexes. Left panel, WB of PP2A in β-catenin immunoprecipitates. Bar
graph, Fold change in PP2A levels in V13 cells was determined in comparison with
the E-cad cells in β-catenin immunoprecipitates after normalization to β-catenin
(**P  0.01). Right panel, Isotype controls for specificity of β-catenin immunoprecipitates. (C) N-glycosylation of E-cadherin does not affect the binding of PP2A
to γ-catenin complexes. Left panel, WB of PP2A in γ-catenin immunoprecipitates.
Bargraph, Fold change in PP2A levels in V13 cells was determined in comparison
with the E-cad cells in γ-catenin immunoprecipitates after normalization to γ-catenin.
No significant change in its association with the γ-catenin complexes was detected.
Right panel, Isotype controls for specificity of γ-catenin immunoprecipitates. Error
bars represent standard deviation from three independent experiments; P values
were calculated by two-tailed t-test.
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Dynein has been shown to interact with E-cadherin
scaffolds through a complex with β-catenin.14,40 Examination of GST pulldowns from E-cadherin- and V13-tranfected
cells showed preferential binding (2–2.5-fold increase)
of dynein to β-catenin in V13-transfectants (Figure 3D).
No association was detected between dynein and γ-catenin
(Figure 3E), confirming that dynein interacted specifically
with β-catenin.

CHO cells expressing V13 exhibit
increased association of γ-catenin
with vinculin
The stability of AJs has been shown to depend on their
interaction with the actin cytoskeleton (8). Our previous
A

studies have shown that in MDCK cells, V13 exhibited an
increased association with γ-catenin and vinculin compared
to wild-type E-cadherin.15 Vinculin is a cytoskeletal protein
known to promote the interaction of AJs with the actin
cytoskeleton.22 Analysis of GST pulldowns from E-cadherin
and V13-transfected cells confirmed that in CHO cells, V13
showed enhanced association with γ-catenin (Figure 4A).
Since β-catenin complexes exhibited greater interaction with
PP2A and dynein, we examined whether γ-catenin complexes
displayed increased interaction with vinculin. Analysis of
vinculin in β-catenin immunoprecipitates showed no significant change between E-cadherin- and V13-transfectants
(Figure 4B). In contrast, the abundance of vinculin in
γ-catenin immunoprecipitates was significantly increased
B
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Figure 3 N-glycosylation status of E-cadherin affects microtubule associated proteins (MAPs), tau and dynein. (A) Effects of N-glycosylation of E-cadherin on α-tubulin
expression and acetylation. WB of α-tubulin expression in total cell lysates (TCLs) from E-cad- and V13-transfected cells. While no significant difference in tubulin expression
was detected, more acetylated α−tubulin was found in V13 cells. Bargraph, Fold changes in α−tubulin and its acetylated pool from V13 cells were determined in comparison
to E-cad cells after normalization to actin (*P  0.05). (B) Effects of N-glycosylation of E-cadheirn on tau expression. WB of tau steady-state levels in TCLs from E-cad- and
V13-transfected cells. No significant differences were detected between E-cad and V13 cells. (C) V13 cells have lower levels of phosphorylated tau. TCLs from E-cad and V13
cells were analyzed for Ser199 and Thr231 phosphorylation of tau. Levels of P-tau were significantly lower in V13 compared to E-cad cells. Bargraph, Fold changes in P-tau levels
in V13 cells were determined in comparison to E-cad cells after normalization to actin (**P  0.01). (D) Recruitment of dynein to β-catenin complexes in E-cad and V13 cells.
β-catenin immunoprecipitates from E-cad and V13 cells were assessed for association with dynein by WB. Bargraph, Fold change of dynein levels in β-catenin immunoprecipitates
from V13 cells was determined in comparison with E-cad cells after normalization to β-catenin (*P  0.05). (E) Association of dynein with γ-catenin complexes is not affected
by N-glycosylation of E-cadherin. Bargraph, Fold change in dynein levels in γ-catenin immunoprecipitates from V13 cells were determined in comparison with E-cad cells after
normalization to γ-catenin. No significant differences were detected between E-cad and V13 cells. Error bars reflect standard deviation from at least three independent studies,
and p-values were calculated by two-tailed t-test.
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(Figure 4C). Therefore, the observed increased interaction
of γ-catenin with vinculin is likely to reflect increased
association of these complexes with the actin cytoskeleton
in V13-transfected CHO cells.
Since stabilization of AJs has been shown to be required
for the mainteneance of tight junctions, we measured the
effect of E-cadherin N-glycosylation on CHO cell TER,
a direct indicator of the tightness of the paracellular seal and
a measure of paracellular permeability. Results showed that
confluent V13 cell monolayers formed TJs that displayed
increased steady-state TER compared to E-cadherin-bearing
cells (Figure 4D).

Enhanced interactions of PP2A
with β-catenin and vinculin with γ-catenin
occur at V13 scaffolds
Our data showing that in V13-expressing CHO cells,
β-catenin bound more PP2A while γ-catenin bound
more vinculin, strongly suggested that these interactions were mediated through a direct association with
V13. It also reflected the presence of distinct V13/β- and
V13/γ-catenin complexes. To prove that V13 formed two
junctional complexes mediated by either β- or γ-catenin,
we used the recently developed double immunoprecipitation technique. 43 This procedure allowed us to
isolate V13 complexes linked to either β- or γ-catenin
and then to identify whether they displayed preferential
association with either PP2A or vinculin. E-cadherin
antibody was immobilized on a column (Profound
Co-immunoprecipitation Kit; Pierce Biotechnology) and
intact V13 complexes that were free from antibody were
isolated using nonreducing elution buffer. This made it
possible to carry out another set of immunoprecipitations for the members of V13 complexes, β-catenin and
γ-catenin. Therefore, the elution sample with antibody-free
V13 complexes was divided in two: one part was used to
immunoprecipitate β-catenin and the other to immunoprecipitate γ-catenin. This led to the isolation of V13/β-catenin
and V13/γ-catenin complexes that could then be probed
for association with PP2A and vinculin by Western blot.
Results showed that significantly more PP2A was associated with V13/β-catenin, while vinculin was exclusively
associated with V13/γ-catenin (Figure 5). In control
studies, only trace amounts of γ-catenin were detected in
the isolated V13/β-catenin complexes, while no β-catenin
was apparent in V13/γ-catenin complexes (Figure 5).
These results provided the first evidence that the hypoglycosylated E-cadherin variant V13 promoted increased
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association with PP2A and vinculin via distinct complexes
mediated by β-catenin and γ-catenin, respectively.

Hypoglycosylated E-cadherin enhances
intercellular adhesion in A253 cancer cells
Recently, we have shown that reduction of cellular
N-glycosylation in A253 cancer cells resulted in a diminished N-glycosylation of E-cadherin, and that this resulted
in enhanced intercellular adhesion and the reversion of
cancer phenotype to an epithelial morphology.19 Since V13
drives the association of AJs with dynein and vinculin, we
examined if tranfection of V13 alone into A253 cells could
promote the formation of mature AJs and enhance intercellular adhesion.
We have previously reported that A253 cancer cells do
not form mature AJs and fail to assemble functional TJs due
to excessive N-glycosylation of endogenous E-cadherin(19).
Immunofluorescence localization of E-cadherin in A253
cells transfected with Flag-tagged wild-type E-cadherin
showed diffuse, primarily cytoplasmic distribution, similar
to that of endogenous E-cadherin (Figure 6A). In contrast,
A253 cells transfected with Flag-V13 displayed wellorganized E-cadherin at cell-cell interfaces (Figure 6A).
The well-localized, continuous staining of E-cadherin in
Flag-V13-expressing cells correlated with intense F-actin
staining, suggesting co-localization (Figure 6A). Furthermore,
in V13 cells, α-catenin was better organized at cell-cell
borders and showed more co-localization with E-cadherin
than in wild-type E-cadherin-expressing cells (Figure 6B).
Biochemical analyses of exogenous Flag-E-cadherin- and
Flag-V13 scaffolds were then carried out with Flag immunoprecipitates from Flag-E-cadherin and Flag-V13-transfected
A253 cells. Results showed that V13 recruited more stabilizing proteins to AJs, including γ-catenin, α-catenin,
vinculin, and PP2A (Figure 6C). The specificity of Flag
immunoprecipitates was confirmed using an isotype control
(Figure 6C, IgG).
The hypoglycosylated variant V13 also enhanced the
integrity of TJs in A253 cells. When plated on Transwell
filters and grown to high density, A253 cells transfected with
V13 displayed a TER value higher than cells transfected with
wild-type E-cadherin (Figure 6D). These results indicate
that AJs with hypoglycosylated E-cadherin enhance cell-cell
adhesion in A253 cancer cells.

Discussion
E-cadherin plays pivotal roles in the maintenance of adult
tissue architecture and in the prevention of tumor spread.
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Figure 4 The hypoglycosylated E-cadherin variant, V13, promotes the interaction of γ-catenin complexes with vinculin. (A) V13 exhibits increased interaction with γ-catenin.
E-cadherin complexes were purified by GST pulldown and analyzed for association with β- and γ-catenins by WB. More γ-catenin was found in V13 complexes compared to
E-cad, while no significant change was detected in the interaction between either E-cad or V13 and β-catenin. Bargraph, Fold changes in β- and γ-catenin levels from V13 cells
were determined in comparison with E-cad cells after normalization to E-cad (*P  0.05). (B) N-glycosylation of E-cadherin does not impact the association of vinculin with
β-catenin complexes. β-catenin immunoprecipitates from E-cad and V13 cells were assessed for association with vinculin by WB. Bargraph, Fold change of vinculin levels in
β-catenin immunoprecipitates from V13 cells was determined in comparison with E-cad cells after normalization to β-catenin. No significant change was detected. (C) V13
cells recruit more vinculin to γ-catenin complexes. γ-catenin immunoprecipitates from E-cad and V13 cells were assessed for association with vinculin by WB. Bargraph, Fold
change of vinculin levels in γ-catenin immunoprecipitates from V13 cells was determined in comparison with E-cad cells after normalization to γ-catenin (**P  0.01). (D) V13
cells display increased TER. TER measurements were carried out with confluent monolayers with duplicate samples. The value of TER for E-cad cells was defined as 1.0. The
results were obtained from three independent experiments (*P  0.05). Error bars were obtained as standard deviation from three independent experiments. P values were
calculated by two-tailed t-test.
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Figure 5 V13 promotes the recruitment of PP2A and vinculin to AJs via distinct
β- and γ-catenin scaffolds. A double immunoprecipitation approach was used to
separate V13/β-catenin and V13/γ-catenin complexes from V13-tranfected CHO cells
(described in Materials and methods). V13-containing complexes, devoid of E-cadherin
antibody, were isolated and subjected to a second round of immunoprecipitation
using antibodies to either β-catenin or γ-catenin. The immunoprecipitates were
then analyzed for β-catenin, γ-catenin, PP2A and vinculin by WB. Results are representative of two independent experiments.

The ability of E-cadherin to perform these functions
depends on the formation of mature AJs that require
interactions with cytoskeletal components, the actin cytoskeleton and most likely with MTs.8,40 Our present studies
provide evidence that interactions of E-cadherin scaffolds
with these cytoskeletal components are affected by the
N-glycosylation status of E-cadherin. Moreover, they show
for the first time that the association of AJs with these two
cytoskeletal components is enhanced through the assembly
of distinct hypoglycosylated E-cadherin-containing scaffolds mediated by either β- or γ-catenins.
Our data show that diminished N-glycosylation of
E-cadherin in CHO cells does not interfere with its targeting to the cell surface (Figure 1B) but rather leads to
the remodeling of AJs (Figures 2–3). Both wild-type and
hypoglycosylated E-cadherins formed more than one
type of complex, either with different components or
with different stoichiometries of association. This is not
surprising in light of the diverse functions of E-cadherin
junctions. The novelty of our finding, however, stems
from the identification of two distinct β- and γ-catenincontaining scaffolds assembled by the hypoglycosylated E-cadherin variant, V13, that drive the association
with different cytoskeletal components. These scaffolds
display increased affinity for dynein, which has been
shown to mediate the association of AJs with MTs, and
vinculin, which mediates association of AJs with the actin
cytoskeleton (Figure 7).
We h ave p r ev i o u s ly s h ow n t h a t ex t e n s ive ly
N-glycosylated E-cadherin inhibited the formation of

Cell Health and Cytoskeleton 2009:1

mature AJs and TJs by interfering with the recruitment
of PP2A to E-cadherin scaffolds. 19 Although to date,
several studies have shown that PP2A is required for the
integrity of AJs, its role(s) in E-cadherin junctions has
not been elucidated. Here, our findings provide the first
molecular explanation for the recruitment of PP2A to AJs.
They show that hypoglycosylated E-cadherin/β-catenin
complexes preferentially bind PP2A and dynein, which
are likely to enhance the tethering of MTs to AJs. Since
such binding of MTs to the sites of AJs has been shown
to enhance the clustering of AJs,10 increased interaction
of hypoglycosylated E-cadherin-containing AJs with MTs
is consistent with the diminished-N-glycosylation-driven
maturation of AJs.
MTs form a well-organized network and run principally
parallel to cell-cell contacts with their (+) ends oriented
towards the basal aspects of cells.44 In epithelial cells, a subpopulation of MTs extends into E-cadherin-based cell-cell
contacts with their (+) ends oriented towards the adhesion
sites.10 MT dynamics are tightly regulated both spatially and
temporally. PP2A has emerged as a key regulator of MT
dynamics by dephosphorylating several major MAPs, such
as tau, which is critical for MT assembly and stabilization,27
and dynein, which enhances this MT-motor protein’s sliding
activity.33,45
Increased recruitment of PP2A to V13-containing AJs
correlated with a three-fold greater abundance of dynein
in β-catenin complexes. Dynein has been shown to bind
β-catenin and to localize at AJs where it tethers MTs to
AJs.14 It is possible that upon increased recruitment to
the hypoglycosylated E-cadherin/β-catenin complex,
PP2A can dephosphorylate dynein and enhance its sliding
activity. Cytoplasmic dyneins are a family of motor proteins that drive movement towards the (-) ends of MTs
and facilitate the transport of vesicles to the apical cell
surface in epithelial cells.46,47 Since hypoglycosylated
E-cadherin-containing AJs drive intercellular adhesion,
their preferential interaction with MTs may also
explain the recently reported role for N-glycosylation in
cell polarity.
Another role of PP2A in AJs is likely to involve the
dephosphorylation of tau, thereby enhancing its stabilizing function and maintaining the normal cellular tubulin:
tau ratio. Tau is known to promote MT nucleation and
assembly, with a cellular tubulin:tau ratio usually being low
at 40:1.48 At this concentration, tau becomes distributed in
a proximal to distal gradient to stabilize MTs and assist
in organelle transport.49,50 Tau hyperphosphorylation is
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Figure 6 Transfection of V13 into A253 cancer cells enhances intercellular adhesion. (A), Immunofluorescence localization of E-cadherin and F-actin in A253 cells following
transfection with either E-cad or V13. E-cadherin from V13 cells exhibit increased co-localization with F-actin at cell-cell contact sites. E-cad and V13 cells were grown to
confluence and processed for indirect immunofluorescence staining using an antibody to the cytoplasmic region of E-cadherin. Cells were counterstained for F-actin with
rhodamine-phalloidin. Shown are 0.74 µm confocal x–y sections. Size bars, 10 µm. (B) Immunofluorescence localization of E-cadherin and α-catenin in A253 cells transfected
with E-cad and V13. Enhanced lateral colocalization of E-cadherin and α-catenin was detected in V13 cells compared to E-cad cells. Shown are 0.74 µm confocal x–y section.
Size bars, 10 µm. (C) A253 cells tranfected with V13 remodel AJs with increased amounts of stabilizing proteins. E-cadherin complexes were immunprecipitated from A253
cells transfected with E-cad and V13 using Flag antibody. Samples were analyzed for association with β-catenin, γ-catenin, α-catenin, vinculin and PP2A by WB. Bargraph, Fold
changes in protein levels associated with E-cadherin from V13 cells were determined in comparison to E-cad after normalization to Flag (*P  0.05). (D) Hypoglycosylated
E-cadherin variant, V13 enhances TER in A253 cells. The TER for nontransfected A253 cells was defined as 1.0. Error bars reflect standard deviation from three independent
studies; P values were calculated by two-tailed t-test.
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Figure 7 Schematic representation of how N-glycosylation of E-cadherin affects cytoskeletal dynamics. Extensively N-glycosylated E-cadherin/β-catenin complexes associate
with less PP2A and dynein compared to hypoglycosylated V13/β-catenin AJs. V13/β-catenin complexes recruit more PP2A, which correlates with dephosphorylation of tau,
and most likely dynein, leading to stabilization of MTs. Also, V13/γ-catenin complexes recruit more vinculin, most likely via α-catenin, which promotes the interaction of AJs
with the actin filaments.
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believed to be the triggering event in the tau aggregation
cascade.51 Clusters of tau on the MTs interfere with the
function of motor proteins and the transport of cytoplasmic material along MTs. Dynein complexes encountering
high concentrations of tau will reverse direction and fail
to transport vesicles to the (-) end of MTs or to the apical
part of the cell.46,47 Indeed, inhibition of PP2A by okadaic
acid has been shown to increase the concentration of P-tau.29
Thus, increased presence of PP2A in the hypoglycosylated
E-cadherin-containing AJs in close proximity to MTs may
confer stability to the overall MT network and promote its
interaction with AJs. Accordingly, our data show that V13transfected cells had less P-tau, which coincides with more
stable MT dynamics.
While phosphorylation of β-catenin at tyrosine
residues has been shown to induce the disassembly of
E-cadherin-catenin complexes from the actin filament
network, inhibition of PP2A by okadaic acid has been
reported to lead to β-catenin’s hyperphosphorylation and
AJ disruption.52 Therefore, the increased recruitment of
PP2A to hypoglycosylated E-cadherin-containing AJs is
also likely to confer stability to the E-cadherin/β-catenin
complex.
Previously, we reported that hypoglycosylated
E-cadherin-containing AJs exhibited increased interaction with γ-catenin, α-catenin, and vinculin.15 Our studies
now extend these observations and show that it is through
a preferential recruitment of γ-catenin that hypoglycosylated E-cadherin complexes interact with vinculin. Because
α-catenin dimers regulate the bundling of the actin filaments,8 and because the interaction of vinculin with F-actin
has been suggested to collaborate with α-catenin to promote
vinculin activation and formation of actin bundles, our studies suggest hypoglycosylated E-cadherin/γ-catenin/vinculin
complexes preferentially mediate the interaction with the
actin cytoskeleton.
It is unclear how the removal of N-glycans induces
changes in the composition of E-cadherin scaffolds. One
possibility is that the extracellular domains of hypoglycosylated E-cadherin form stronger bonds in trans that
lead to a conformational change in cis of the cytoplasmic
domain. Since E-cadherin-mediated adhesion is known to be
regulated by its cytoplasmic domain, V13-driven conformational change may result in an increased affinity of AJs for
stabilizing proteins.53 Here, we show that hypoglycosylated
E-cadherin organizes two distinct β- and γ-catenin-mediated
scaffolds with increased stoichiometries of stabilizing
proteins.
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Collectively, our studies reveal novel insights into the
roles of N-glycosylation in AJ remodeling and cytoskeletal
interactions. We show that hypoglycosylated E-cadherin
drives the formation of mature AJs through the organization
of two distinct junctional complexes that are likely to promote
the interaction of AJs with either the actin cytoskeleton or
MTs (Figure 7). Hypoglycosylated E-cadherin/β-catenin
complexes preferentially recruit PP2A and dynein. The
presence of PP2A in close proximity to dynein suggests
that PP2A can dephosphorylate dynein, enhance its motor
activity, and promote the tethering of MTs to AJs. Moreover,
increased association of PP2A with AJs tethered to MTs is
likely to maintain tau in a dephosphorylated state, providing
strength and support to the MT network. In addition to promoting AJ clustering, the tethering of MTs to AJs may serve
to coordinate the maturation of AJs with the MT-directed
transport of polarity proteins to the apical domain and with
the establishment of cell polarity. On the other hand, hypoglycosylated E-cadherin/γ-catenin complexes preferentially
mediate the interaction with the actin cytoskeleton through
the recruitment of vinculin. Thus, protein N-glycosylation
has now emerged as one of the key regulators of intercellular adhesion and cytoskeletal dynamics, highlighting the
cross talk between cellular metabolism and cell structure
and behavior.
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